These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 13878496)

  • 21. Absorption measurements for broad beams of 1- and 2-million-volt X-rays.
    SINGER G; BRAESTRUP CB; WYCKOFF HO
    J Res Natl Bur Stand (1934); 1946 Aug; 37(2):147-50. PubMed ID: 20999090
    [No Abstract]   [Full Text] [Related]  

  • 22. A control circuit for a pneumatic-transfer teletherapy unit.
    BURNS JE; TROTMAN RE
    Br J Radiol; 1960 Jan; 33():63-4. PubMed ID: 13806252
    [No Abstract]   [Full Text] [Related]  

  • 23. Cobalt 60 beam therapy.
    EVANS AM; MOFFAT RG; NASH RD; BATHO HF; MIBUS SA
    J Fac Radiol; 1954 Apr; 5(4):248-60. PubMed ID: 24543588
    [No Abstract]   [Full Text] [Related]  

  • 24. Carmustine, etoposide, cytarabine, and melphalan (BEAM)-campath allogeneic stem cell transplantation for aggressive non-hodgkin lymphoma: an analysis of outcomes from the British Society of Blood and Marrow Transplantation.
    Truelove E; Fox C; Robinson S; Pearce R; Perry J; Kirkland K; McQuaker G; Pagliuca A; Johnson P; Russell N; Cook G;
    Biol Blood Marrow Transplant; 2015 Mar; 21(3):483-8. PubMed ID: 25490180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-dose CEB vs BEAM with autologous stem cell transplant in lymphoma.
    Wang EH; Chen YA; Corringham S; Bashey A; Holman P; Ball ED; Carrier E
    Bone Marrow Transplant; 2004 Oct; 34(7):581-7. PubMed ID: 15273714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physical studies on a short-treatment-distance cesium-137 teletherapy unit.
    COLE A; SINCLAIR WK; FLETCHER GH; JOHNSON GC
    Radiology; 1960 May; 74():731-42. PubMed ID: 13811103
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparison of 2 Carmustine-Containing Regimens in the Rituximab Era: Excellent Outcomes Even in Poor-Risk Patients.
    Caimi PF; William BM; Silva Rondon CH; Fu P; Cooper BW; Campagnaro EL; Gerson SL; Reese-Koc J; Fox R; Creger RJ; de Lima M; Lazarus HM
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):1926-31. PubMed ID: 26087475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. World survey of radioisotope teletherapy units.
    TSIEN KC
    Am J Roentgenol Radium Ther Nucl Med; 1962 Mar; 87():593-9. PubMed ID: 13922796
    [No Abstract]   [Full Text] [Related]  

  • 29. LACE versus BEAM conditioning in relapsed and refractory lymphoma transplant: retrospective multicenter analysis of toxicity and efficacy.
    Khattry N; Gupta A; Jain R; Gore A; Thippeswamy R; Jeevangi N; Kannan S; Nair R; Saikia T
    Int J Hematol; 2016 Mar; 103(3):292-8. PubMed ID: 26729297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study.
    Chiappella A; Martelli M; Angelucci E; Brusamolino E; Evangelista A; Carella AM; Stelitano C; Rossi G; Balzarotti M; Merli F; Gaidano G; Pavone V; Rigacci L; Zaja F; D'Arco A; Cascavilla N; Russo E; Castellino A; Gotti M; Congiu AG; Cabras MG; Tucci A; Agostinelli C; Ciccone G; Pileri SA; Vitolo U
    Lancet Oncol; 2017 Aug; 18(8):1076-1088. PubMed ID: 28668386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A new cobalt teletherapy apparatus].
    WALTER E
    Strahlentherapie; 1959; Suppl 43():435-43. PubMed ID: 13842691
    [No Abstract]   [Full Text] [Related]  

  • 32. Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial.
    Schmitz N; Pfistner B; Sextro M; Sieber M; Carella AM; Haenel M; Boissevain F; Zschaber R; Müller P; Kirchner H; Lohri A; Decker S; Koch B; Hasenclever D; Goldstone AH; Diehl V; ;
    Lancet; 2002 Jun; 359(9323):2065-71. PubMed ID: 12086759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An "all-shape" diaphragm for high-energy teletherapy units.
    LANDAUER RS; BYUN HH; MAGALOTTI MF
    Radiology; 1960 Nov; 75():806-8. PubMed ID: 13758655
    [No Abstract]   [Full Text] [Related]  

  • 34. Leaks in standard sealed teletherapy sources.
    CLOUTIER RJ; BRUCER M
    Health Phys; 1961 Aug; 6():32-5. PubMed ID: 13694138
    [No Abstract]   [Full Text] [Related]  

  • 35. Pegfilgrastim appears equivalent to daily dosing of filgrastim to treat neutropenia after autologous peripheral blood stem cell transplantation in patients with non-Hodgkin lymphoma.
    Rifkin R; Spitzer G; Orloff G; Mandanas R; McGaughey D; Zhan F; Boehm KA; Asmar L; Beveridge R
    Clin Lymphoma Myeloma Leuk; 2010 Jun; 10(3):186-91. PubMed ID: 20511163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Auxiliary diaphragm for radioisotope teletherapy units.
    WALSTAM R
    Acta Radiol (Stockh); 1962 Jun; 58():201-9. PubMed ID: 14040154
    [No Abstract]   [Full Text] [Related]  

  • 37. BEAM Conditioning Regimen Has Higher Toxicity Compared With High-Dose Melphalan for Salvage Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma.
    Veeraputhiran M; Jain T; Deol A; Ayash L; Kim S; Dyson G; Bhutani D; Lum LG; Ratanatharathorn V; Uberti JP; Abidi MH
    Clin Lymphoma Myeloma Leuk; 2015 Sep; 15(9):531-5. PubMed ID: 26166312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dexa-BEAM in patients with Hodgkin's disease refractory to multidrug chemotherapy regimens: a trial of the German Hodgkin's Disease Study Group.
    Pfreundschuh MG; Rueffer U; Lathan B; Schmitz N; Brosteanu O; Hasenclever D; Haas R; Kirchner H; Koch P; Kuse R
    J Clin Oncol; 1994 Mar; 12(3):580-6. PubMed ID: 8120557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A mononuclear cell dose of 3 x 10(8)/kg predicts early multilineage recovery in patients with malignant lymphoma treated with carmustine, etoposide, Ara-C and melphalan (BEAM) and peripheral blood progenitor cell transplantation.
    Smith RJ; Sweetenham JW
    Exp Hematol; 1995 Dec; 23(14):1581-8. PubMed ID: 8542950
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of conditioning regimen on outcome of 2-year disease-free survivors of autologous stem cell transplantation for Hodgkin lymphoma.
    William BM; Loberiza FR; Whalen V; Bierman PJ; Bociek RG; Vose JM; Armitage JO
    Clin Lymphoma Myeloma Leuk; 2013 Aug; 13(4):417-23. PubMed ID: 23773453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.